Metoprolol Succinat Ratiopharm (Metoprolol Tartrate)

• Metoprolol is a selective β1‑adrenergic receptor antagonist used in several cardiovascular conditions.
• Hypertension: lowers blood pressure by reducing heart rate and cardiac output.
• Angina pectoris: decreases myocardial oxygen demand, relieving chest pain.
• Heart failure: improves ventricular function and reduces hospitalisation risk.
• Post‑myocardial infarction prophylaxis: lowers the chance of recurrent cardiac events.
• Cardiac arrhythmias: helps control abnormal heart rhythms, particularly supraventricular tachycardia.

• Metoprolol selectively blocks β1‑adrenergic receptors in the heart, inhibiting the effects of endogenous catecholamines. This reduces heart rate, myocardial contractility, and renin release, leading to decreased cardiac output and lower arterial pressure. The drug’s action is dose‑dependent and primarily affects cardiac tissue, sparing β2 receptors in the lungs and vasculature at therapeutic concentrations.

Metoprolol may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Fatigue or tiredness
• Dizziness or light‑headedness
• Cold hands and feet
• Headache
• Bradycardia (slow heart rate)
• Mild gastrointestinal upset (nausea, abdominal discomfort)

Serious or Rare Side Effects

• Severe bradycardia or heart block
• Marked hypotension
• Bronchospasm in susceptible individuals
• Depression or mood changes
• Allergic reactions (rash, angioedema)
• Worsening heart failure symptoms

• Before prescribing Metoprolol, clinicians should evaluate patient‑specific factors and monitor for potential risks.
• Assess cardiovascular status: evaluate heart rate and blood pressure prior to initiation.
• Monitor for bronchospasm: avoid use in patients with active asthma or severe COPD.
• Adjust dose in renal impairment: consider reduced dosing in patients with decreased renal function.
• Review concomitant medications: check for drugs that may enhance bradycardia or hypotension.
• Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Metoprolol can interact with several drug classes, requiring careful assessment.

Major Interactions (Avoid)

• Other AV‑node blockers (e.g., verapamil, diltiazem) – risk of profound bradycardia.
• Strong CYP2D6 inhibitors (e.g., paroxetine, fluoxetine) – increase Metoprolol plasma levels.
• Insulin or oral hypoglycemics – may mask hypoglycaemia symptoms.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – reduce antihypertensive effect.
• Amiodarone – additive negative chronotropic effect.

Moderate Interactions (Monitor Closely)

• Calcium‑channel blockers (e.g., amlodipine) – may modestly lower blood pressure.
• Diuretics – potential for excessive blood pressure reduction.
• ACE inhibitors or ARBs – monitor for additive hypotensive response.